XIST and bladder transitional cell carcinoma: The results demonstrated that TET1 can promote p53 expression by binding to the promoter region of p53, while XIST inhibits p53 expression by binding to TET1. These findings suggest that XIST acts as an epigenetic regulator, directly interacting with TET proteins and affecting their functions in BLCA (41).